Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NATOS Protocol for Good Prognosis IVF-ET Patients
NCT02892942Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2017
- Primary completion
- Feb 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cetrorelix in infertility (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Live birth obtained after IVF-ET. Started Jan 2017; status: completed.
02
Drugs
cetrorelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02892942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02892942.